Similar articles for PMID: 28408526

Year	Number of Results
1992	1
1997	1
2002	2
2003	1
2007	1
2009	3
2011	2
2012	4
2013	4
2014	2
2015	6
2016	21
2017	21
2018	5
2019	1
2020	1
2021	1
2022	1
2023	2
2024	0

1

⁶⁸Ga or ¹⁸F for Prostate Cancer Imaging?

Kesch C, Kratochwil C, Mier W, Kopka K, Giesel FL. Kesch C, et al. J Nucl Med. 2017 May;58(5):687-688. doi: 10.2967/jnumed.117.190157. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408526 Free article. No abstract available.

2

Validation of a [Al¹⁸F]PSMA-11 preparation for clinical applications.

Al-Momani E, Israel I, Samnick S. Al-Momani E, et al. Appl Radiat Isot. 2017 Dec;130:102-108. doi: 10.1016/j.apradiso.2017.09.003. Epub 2017 Sep 6. Appl Radiat Isot. 2017. PMID: 28950199

3

Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.

Chatalic KL, Franssen GM, van Weerden WM, McBride WJ, Laverman P, de Blois E, Hajjaj B, Brunel L, Goldenberg DM, Fehrentz JA, Martinez J, Boerman OC, de Jong M. Chatalic KL, et al. J Nucl Med. 2014 Dec;55(12):2050-6. doi: 10.2967/jnumed.114.141143. Epub 2014 Nov 20. J Nucl Med. 2014. PMID: 25413139 Free article.

4

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L. Morigi JJ, et al. J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25. J Nucl Med. 2015. PMID: 26112024 Free article.

5

Synthesis and pre-clinical evaluation of a new class of high-affinity ¹⁸F-labeled PSMA ligands for detection of prostate cancer by PET imaging.

Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C Jr, Ponnala S, Babich JW. Kelly J, et al. Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15. Eur J Nucl Med Mol Imaging. 2017. PMID: 27847991 Free PMC article.

6

Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.

Hofman MS, Iravani A. Hofman MS, et al. PET Clin. 2017 Apr;12(2):219-234. doi: 10.1016/j.cpet.2016.12.004. Epub 2017 Feb 1. PET Clin. 2017. PMID: 28267455 Review.

7

The Role of Positron Emission Tomography With (68)Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy.

Rai BP, Baum RP, Patel A, Hughes R, Alonzi R, Lane T, Adshead J, Vasdev N. Rai BP, et al. Urology. 2016 Sep;95:11-5. doi: 10.1016/j.urology.2015.12.048. Epub 2016 Jan 11. Urology. 2016. PMID: 26790588 Review.

8

PSMA ligands in prostate cancer - Probe optimization and theranostic applications.

Lütje S, Slavik R, Fendler W, Herrmann K, Eiber M. Lütje S, et al. Methods. 2017 Nov 1;130:42-50. doi: 10.1016/j.ymeth.2017.06.026. Epub 2017 Jun 28. Methods. 2017. PMID: 28666778 Review.

9

Imaging of Prostate Cancer Using Gallium-68-Labeled Bombesin.

Sonni I, Baratto L, Iagaru A. Sonni I, et al. PET Clin. 2017 Apr;12(2):159-171. doi: 10.1016/j.cpet.2016.11.003. Epub 2017 Jan 20. PET Clin. 2017. PMID: 28267450 Review.

10

Clinical PET Imaging in Prostate Cancer.

Wallitt KL, Khan SR, Dubash S, Tam HH, Khan S, Barwick TD. Wallitt KL, et al. Radiographics. 2017 Sep-Oct;37(5):1512-1536. doi: 10.1148/rg.2017170035. Epub 2017 Aug 11. Radiographics. 2017. PMID: 28800286 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year